Caleb Talley, Jeff Amerine, and Davis McEntire sit down with Louis Bowen, co-founder of Pacific GeneTech Limited as well as founder of Asia Capital Management Limited in Hong Kong. In this week's episode, we discuss Louis' entrepreneurial journey, his relocation to Hong Kong along the way, and how he tackled making a difference in the Asian markets as he founded one of the first private investment banking firms in the area as well as operating Pacific GeneTech, a vaccination development and commercialization firm.
Don't miss this one, tune in!
(1:16) Introducing Louis Bowen
(6:08) Pacific GeneTech
(13:14) Long Cycle Commercialization of Intellectual Property
(18:44) H5N1 Scare
(23:44) Raising Capital Internationally Vs. Domestically
(27:08) Evolution of Asian Market Today
(34:21) Pacific GeneTech and NWA
(37:13) Human Health and on The Horizon
(39:13) Advice to Younger Self
(38:13) Wrap Up
"Not many entrepreneurs have an appreciation for how long-cycle commercialization of intellectual property, particularly as it relates to human or even animal health, requires a kind of long-term commitment and patience."
(13:18) - Jeff Amerine
"One reason why we chose Northwest Arkansas was that we wanted to be close to the source of technology, we wanted to continue to work with the university."
(31:20) - Louis Bowen
"There's a real skill in being able to take technology out of the lab and turn it into a reality."
(35:01) - Louis Bowen
"I probably felt as though I could solve more problems than I could in the investing world. You know, nothing goes in a straight line. There's nothing linear investing in early businesses, early stage businesses."
(40:48) - Louis Bowen